Matthew Angel - Jan 12, 2023 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
President and CEO, Director
Signature
/s/ Matthew Angel
Stock symbol
ERNA
Transactions as of
Jan 12, 2023
Transactions value $
$0
Form type
4
Date filed
1/13/2023, 06:30 PM
Previous filing
Aug 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +132K $0.00 132K Jan 12, 2023 Common Stock, par value $0.005 per share 132K $4.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vests and becomes exercisable over three years (subject to continued service), with 110,043 of the shares vesting on the grant date, and the remaining shares vesting in 36 substantially equal monthly tranches on the first day of each month thereafter.